Thrombolytics


Also found in: Encyclopedia.

Thrombolytics

Drugs that dissolve blood clots. Thrombolytics are used to treat embolisms.
Mentioned in: Embolism
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.
References in periodicals archive ?
In this investigational study the device is used to administer thrombolytics through multiple cross-sections of the culprit clot to enhance clot dissolution.
Data on the use of thrombolytics in patients with severe hypoxemia, PTE-related cardiopulmonary arrest, and free thrombus in the right ventricle or atrium are limited, and a case-based approach is recommended [27].
The updated guidelines on management of acute PE indicate that thrombolytics should be considered as it follows: 1.
In another study in elderly patients prolonged and low dose infusions of thrombolytics showed an initial and cumulative success rates of 40.7% and 85.2%, respectively12.
Thrombolytics have been used successfully, mostly late in CPR after initial unresponsiveness to traditional advanced cardiac life support (ACLS) [6-11].
Mean tricuspid annular peak systolic velocity (Sa) was 11.4 [+ or -] 2.3 cm/s in patients who were given thrombolytic therapy compared to 11.2 [+ or -] 2.2 cm/s in whom thrombolytics were not given.
Myocardial infarction in the elderly: benefits and risks of thrombolytics. Drug Saf 2002; 25: 753-8.
Comparative efficacy of thrombolytics in acute myocardial infarction: A systematic review.
Thrombolytics are often used to dissolve or reduce the size of the thromboembolism and improve haemodynamic status and gas exchange.
Overall, 7% of patients with ischemic stroke were treated with intravenous thrombolytics. Interestingly, 11 of 15 of the hospitals (73%) with an established protocol also had a designated stroke team, in contrast to those without an established protocol whose patients were treated by teams in the ED (10/15 or 67%).
Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke.
Anticoagulants, antiplatelets, and thrombolytics, 2d ed.